Combined positron emission tomography–computed tomography and tumor markers for detecting recurrent ovarian cancer
Autor: | Hun-Shan Pan, Lee-Wen Huang, Yen-Kung Chen, Shiow-Lin Lee |
---|---|
Rok vydání: | 2010 |
Předmět: |
Adult
medicine.medical_specialty Exploratory laparotomy medicine.medical_treatment Physical examination Adenocarcinoma Sensitivity and Specificity Fluorodeoxyglucose F18 Predictive Value of Tests Positive predicative value Biomarkers Tumor medicine Humans Aged Tumor marker Ovarian Neoplasms medicine.diagnostic_test business.industry Obstetrics and Gynecology General Medicine Middle Aged medicine.disease Positron emission tomography Positron-Emission Tomography Predictive value of tests Female Radiology Neoplasm Recurrence Local Radiopharmaceuticals Tomography X-Ray Computed Ovarian cancer business Nuclear medicine Recurrent Ovarian Carcinoma |
Zdroj: | Archives of Gynecology and Obstetrics. 283:335-341 |
ISSN: | 1432-0711 0932-0067 |
DOI: | 10.1007/s00404-010-1404-6 |
Popis: | To evaluate the accuracy of integrated FDG-PET/CT and tumor markers for the depiction of recurrent ovarian carcinoma. Patients with pathologically proven ovarian cancer, who underwent cytoreductive surgery and 3–6 cycles of adjuvant chemotherapy, were included in this study. They all underwent a thorough physical examination, tumor marker determination, and FDG-PET/CT imaging. The sensitivity, specificity, accuracy, and positive and negative predictive values for the tumor detection with PET/CT versus different tumor markers were performed in relation to the results at histological analysis after second-look surgery or clinical follow-up. A total of 37 patients underwent FDG-PET/CT scans. Among them, 22 patients underwent exploratory laparotomy and 15 had diagnostic laparoscopy. Overall, 24 patients were documented to have ovarian cancer recurrence after second operation. FDG-PET/CT had sensitivity, specificity, accuracy, and positive and negative predictive values of 100, 85, 94, 92, and 100%, respectively. Our study has shown that PET/CT is a sensitive tool to assist in the early identification and recurrent ovarian cancer, amenable to secondary cytoreduction. |
Databáze: | OpenAIRE |
Externí odkaz: |